Access site-related infection in dialysis: The AStRID project. A multicenter prospective Italian study

Journal of Nephrology

Volumn 17, Issue 2, 2004, Pages 223-227

  Viale, Pier Luigi ^a   Brunori, Giuliano ^b   Petrosillo, Nicola ^c   Scudeller, Luigia ^a   Beltrame, Anna ^a   Sottini, Laura ^b   Cancarini, Giovanni ^b   Brusaferro, Silvio ^a   Maiorca, Rosario ^b   Carosi, Giampiero ^b   Piazza, V ^d   Efficace, E ^d   Fregonese, C ^e   Mioni, G ^e   Bracchi, M ^f   Pola, A ^f   De Marinis, S ^f   Delfino, D F ^g   Zoccali, C ^g   La Russa, A ^h   Malberti, F ^h   Losi, B ⁱ   Brancaccio, D ⁱ   Talassi, E ^j   Tarchini, R ^j   Lucchi, L ^k   Albertazzi, A ^k   more..

^a UNIVERSITY OF UDINE   (Italy)

^b SPEDALI CIVILI   (Italy)

^c National Institute of Infectious Disease L Spallanzani   (Italy)

^d IRCCS   (Italy)

^e Division of Nephrology   (Italy)

^f Civic Hospital   (Italy)

^g Civic Hospital   (Italy)

^h Civic Hospital   (Italy)

ⁱ SAN PAOLO HOSPITAL   (Italy)

^j CARLO POMA HOSPITAL   (Italy)

^k UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

more..

Author keywords

Bloodstream infection; Chronic hemodialysis; Sepsis; Vascular access infection

Indexed keywords

ARTICLE; BACTEREMIA; BLOOD VESSEL FISTULA; BLOOD VESSEL GRAFT; CENTRAL VENOUS CATHETERIZATION; CONTROLLED STUDY; DATA ANALYSIS; HEALTH CARE FACILITY; HEMATOLOGIC DISEASE; HEMODIALYSIS; HUMAN; INCIDENCE; INFECTION COMPLICATION; ITALY; KIDNEY FAILURE; PROSPECTIVE STUDY; QUALITY CONTROL; SAMPLING; SEPSIS; STATISTICAL ANALYSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; VASCULAR ACCESS;

HUMANS; INCIDENCE; ITALY; KIDNEY FAILURE, CHRONIC; PROSPECTIVE STUDIES; PROSTHESIS-RELATED INFECTIONS; RENAL DIALYSIS; SURGICAL WOUND INFECTION; VASCULAR SURGICAL PROCEDURES;

EID: 2942685049     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Kessler M, Hoen B, Mayeux D, Hestin D, Fontenaille C. Bacteremia in patients on chronic hemodialysis. Nephron 1993; 664: 95-100.
2. Churchill DN, Taylor DW, Cook RJ, LePlante P, Barre P, Cartier P, Fay WP, Goldstein MB, Jindal K, Mandin H. Canadian hemodialysis morbidity study. Am J Kidney Dis 1992; 19: 214-34.
3. Gaynes RP, Culver DH, Emori TG, Horan TC, Banerjee SN, Edwards JR, Tolson JS, Henderson TS. The National Nosocomial Infections Surveillance System: Plans for the 1990s and beyond. Am J Med 1991; 91 (suppl 3B): S116-20.
4. Stevenson KB, Acdcox MJ, Mallea MC, Narasimhan N; Wagnild JP. Standardized surveillance of hemodialysis vascular access infections: 18-month experience at an outpatient, multifacility hemodialysis center. Infect Control Hosp Epidemol 2000; 21: 200-3.
5. Taylor G, McKenzie M, Buchanan-Chell M, Perry D, Chui L, Dasgupta M. Central venous catheter as a source of hemodialysis related bacteremia. Infect Control Hosp Epidemol 1998; 19: 643-6.
6. Oliver MJ, Callery SM, Thorpe KE, Schwab SJ, Churchill DN. Risk of bacteremia from temporary hemodialysis catheters by site of insertion and duration of use: a prospective study. Kidney Int 2000; 58: 2543-5.
7. Deneuville M. Infection of PTFE grafts used to create arteriovenous fistula for hemodialysis access. Ann Vasc Surg 2000; 14: 473-9.
8. Tanriover B, Carlton D, Saddekni S, Hamrick K, Oser R, Westfall AO, Allon M. Bacteremia associated with tunneled dialysis catheters: comparison of two treatment strategies. Kidney Int 2000; 57: 2151-5.
9. Saad TF. Bacteremia associated with tunneled, cuffed hemodialysis catheters. Am J Kidney Dis 1999; 34: 1114-24.
10. http://www.cdc.gov.ncidod/hip/Dialysis/dialysis/htm
11. Pisoni RL, Young EW, Dykstra DM, Greenwood RN, Hecking E, Gillespie B, Wolfe RA, Goodkin DA, Held JP. Vascular access use in Europe and the United States: Results from the DOPPS. Kidney Int 2002; 61: 305-16.
12. Padberg Jr FT, Lee BC, Curl GR. Hemoaccess site infection. Surg Gynecol Obstet 1992; 174: 103-8.
13. Bonomo RA, Rice D, Whalen C, Linn D, Eckstein L, Shales DM. Risk factors associated with permanent access site infections in chronic hemodialysis patients. Infect Control Hosp Epidemiol 1997; 18: 757-61.
14. Kaplowitz LG, Comstock JA, Landwehr DM, Dalton HP, Mayhall GA. A prospective study of infections in hemodialysis patients: patient hygiene and other risk factors for infection. Infect Control Hosp Epidemiol 1988; 9: 534-41.
15. Chazan JA, London MR, Pono LM. Long-term survival of vascular accesses in a large chronic hemodialysis population. Nephron 1995; 69: 228-33.
16. Cheesebrough JS, Finch RG, Burden RP. A prospective study of the mechanisms of infections associated with hemodialysis catheters. J Infect Dis 1986; 154: 579-89.
17. ACCP/SCCM Consensus Conference - Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101: 1644-55.
18. Garner JS, Jarvis WR, Emori TG. CDC definitions for nosocomial infections. Am J Infect Control 1988; 16: 128-40.
19. Kim SD, McDonald LC, Jarvis WR. Determining the significance of coagulase negative Staphylococci isolated from blood cultures at a community hospital: a role for species and strains identification. Infect Control Hosp Epidemiol 2000; 21: 213-17.
20. Reimer LG, Wilson ML, Weinstein MP. Update on detection of bacteriemia and fungemia. Clin Microbiol Rev 1997; 10: 444-65.
21. Maki DG, Weiss CE, Sarafin HW. Semiquantitative method for identifying intravenous catheter related infections. N Engl J Med 1977; 269: 1305-9.
22. Brun-Buisson C, Abrouk F, Legrand P. Diagnosis of CVC related sepsis. Critical level of quantitative tip cultures. Arc Intern Med 1987; 147: 873-7.
23. Pearson ML for Centers for Diseases Control and Prevention. Guideline for prevention on intravascular device-related infections. Am J Infect Control 1996; 24: 262-93.
24. Centers for Disease Control and Prevention. Guidelines for prevention of intravascular catheter-related infections. MMWR Morb Mortal Wkly Rep 2002; 51 (No RR-10).
25. Centers for Disease Control and Prevention. Update: Staphylococcus aureus with reduced susceptibility to vancomycin. United States, 1997. MMWR Morb Mortal Wkly Rep 1997; 46: 813-5.
26. Centers for Disease Control and Prevention. Recommendation for preventing the spread of vancomycin resistence. MMWR Morb Mortal Wkly Rep 1995; 44 (No RR-12): 1-12.
27. Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin United States, 1989-1993. MMWR Morb Mortal Wkly Rep 1993; 42: 597-9.
28. World Medical Association. Declaration of Helsinki: Recommendations guiding physicians in biomedical research involving human subjects. IVth adaptation 1989.
29. Lebacqz K, Levine RJ. Respect for person and informed consent to participate in research. Clin Res 1977; 25: 101-7.